Canaccord Genuity maintains Buy rating on Clover Health, lowers PT to $3.2.

viernes, 20 de marzo de 2026, 11:05 am ET1 min de lectura
CLOV--

Canaccord Genuity maintains Buy rating on Clover Health, lowers PT to $3.2.

Canaccord Genuity maintains Buy rating on Clover Health, lowers PT to $3.2.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios